# Bupropion for the Treatment of Methamphetamine Dependence - 1

> **NCT00069251** · PHASE2 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 150 (—)

## Conditions studied

- Amphetamine-Related Disorders

## Interventions

- **DRUG:** Bupropion

## Key facts

- **NCT ID:** NCT00069251
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** —
- **Final completion:** 2005-06
- **Target enrollment:** 150 (—)
- **Last updated:** 2017-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00069251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00069251, "Bupropion for the Treatment of Methamphetamine Dependence - 1". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00069251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*